24
Mon, Sep

US Panel Recommends New Adult Vaccine Against Hepatitis B

Health
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times
The new vaccine uses an additive that boosts the body's immune response. It is two shots given over one month.
Share/Save/Bookmark

A federal advisory panel is recommending a new vaccine against hepatitis B.

The vaccine called Heplisav-B was licensed in November and is the first new hepatitis B vaccine in 25 years.

Hepatitis B vaccines have been in childhood shots for decades. The new vaccine is for adults.

The hepatitis B virus can damage the liver and is spread through contact with blood or other bodily fluids. Cases have been rising, a trend linked to the heroin and opioid epidemic. Meanwhile, researchers found older vaccines falter in diabetics and older adults.

The new vaccine uses an additive that boosts the body's immune response. It is two shots given over one month.

The Advisory Committee on Immunization Practices endorsed the vaccine Wednesday in Atlanta. The government usually adopts its recommendations.

 

Source: VOA

BLOG COMMENTS POWERED BY DISQUS
Sign up via our free email subscription service to receive notifications when new information is available.